Vildagliptin Attenuates Cardiac Hypertrophy and Improves Ventricular Efficiency Through FGF21 Expression in Pressure-overloaded Mouse Heart

被引：0
|
作者：
Furukawa, Nozomi
Koitabashi, Norimichi
Sunaga, Hiroaki
Obokata, Masaru
Umbarawan, Yogi
Syamsunarno, Mas R.
Yamaguchi, Aiko
Matsui, Hiroki
Yokoyama, Tomoyuki
Kurabayashi, Masahiko
机构：
来源：
CIRCULATION | 2016年 / 134卷
关键词：
Ventricular remodeling; Energy metabolism; Fibrosis; Diabetes Mellitus; Gene expression;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
12454
引用
收藏
页数：2
相关论文
共 46 条
  • [21] Gab1 Overexpression Attenuates Susceptibility to Ventricular Arrhythmias in Pressure Overloaded Heart Failure Mouse Hearts
    Liu, Mingxin
    Zhao, Jianhua
    Lu, Yonghua
    Chen, Zhi
    Feng, Xiaojian
    Pan, Gang
    CARDIOVASCULAR DRUGS AND THERAPY, 2024, 38 (02) : 253 - 262
  • [22] BIAXIAL STRESS-STRAIN RELATIONSHIPS OF THE DIASTOLIC CARDIAC-MUSCLE AND STRESSES IN LEFT-VENTRICULAR WALL FOR THE PRESSURE-OVERLOADED HEART
    NAKAMURA, T
    KIMURA, T
    KUSHIBIKI, H
    MOTOMIYA, M
    KONNO, K
    SUZUKI, N
    ARAI, S
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1981, 45 (08): : 957 - 958
  • [23] Increased cardiac expression of TIMP-1 and TIMP-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart
    Heymans, S
    Schroen, B
    Vermeersch, P
    Milting, H
    Herijgers, P
    Carmeliet, P
    Van de Werf, F
    Pinto, YM
    CIRCULATION, 2005, 112 (17) : U410 - U411
  • [24] Increased cardiac expression of TIMP-1 and TIMP-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart
    Heymans, S.
    Schroen, B.
    Milting, H.
    Herijgers, P.
    Carmeliet, P.
    Van de Werf, F.
    Pinto, Y. M.
    Janssens, S.
    EUROPEAN HEART JOURNAL, 2005, 26 : 119 - 119
  • [25] Increased cardiac expression of TIMP-1 and TIMP-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart.
    Heymans, S
    Schroen, B
    Vermeersch, P
    Milting, H
    Herijgers, P
    Carmeliet, P
    Van de Werf, F
    Janssens, S
    Pinto, Y
    HYPERTENSION, 2005, 46 (04) : 900 - 900
  • [26] Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1α and vascular endothelial growth factor in pressure-overloaded rat heart
    Shyu, KG
    Liou, JY
    Wang, BW
    Fang, WJ
    Chang, H
    JOURNAL OF BIOMEDICAL SCIENCE, 2005, 12 (02) : 409 - 420
  • [27] Chronic sympathectomy improves survival and attenuates cardiac dysfunction during the progression of pressure-overload hypertrophy to heart failure
    Perlini, S
    Ferrero, I
    Fallarini, S
    Palladini, G
    Tozzi, R
    Radaelli, A
    Busca, G
    Ferrari, AU
    EUROPEAN HEART JOURNAL, 2003, 24 : 15 - 15
  • [28] Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure
    Gesmundo, Iacopo
    Miragoli, Michele
    Carullo, Pierluigi
    Trovato, Letizia
    Larcher, Veronica
    Di Pasquale, Elisa
    Brancaccio, Mara
    Mazzola, Marta
    Villanova, Tania
    Sorge, Matteo
    Taliano, Marina
    Gallo, Maria Pia
    Alloatti, Giuseppe
    Penna, Claudia
    Hare, Joshua M.
    Ghigo, Ezio
    Schally, Andrew V.
    Condorelli, Gianluigi
    Granata, Riccarda
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (45) : 12033 - 12038
  • [29] Subinflammatory Amount of Interleukin-1 Is Constitutively Produced by Cyclically Stretched Cardiac Cells and Induces IGF-1 Through JAK/STAT Pathway, Which Is Required for Compensated Hypertrophy in Pressure-Overloaded Heart
    Okigaki, Mitsuhiko
    Honsho, Shoken
    Nishikawa, Susumu
    Matsubara, Hiroaki
    CIRCULATION RESEARCH, 2008, 103 (05) : E69 - E69
  • [30] Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart
    Heymans, S
    Schroen, B
    Vermeersch, P
    Milting, H
    Gao, FY
    Kassner, A
    Gillijns, H
    Herijgers, P
    Flameng, W
    Carmeliet, P
    de Werf, FV
    Pinto, YM
    Janssens, S
    CIRCULATION, 2005, 112 (08) : 1136 - 1144
12345